Advertisement
Screener

WEIKANG BIO-TECHNOLOGY GROUP CO., INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities

WEIKANG BIO-TECHNOLOGY GROUP CO., INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities

WEIKANG BIO-TECHNOLOGY GROUP CO., INC. reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$105.40 thousand for the 9-month period ending 2012-09-30, per its 10-Q/A filed 2012-12-11.

Discontinued › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2012-12-11

  • WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2012-09-30 was $8.17K.
  • WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2012-06-30 was -$38.19K.
  • WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2012-03-31 was -$75.37K, a 318.52% decline year-over-year.
  • WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2011-12-31 was $76.05K, a 93.21% decline year-over-year.
  • WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2011 was -$689.13K, a 151.18% decline from fiscal 2010.
  • WEIKANG BIO-TECHNOLOGY GROUP CO., INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2010 was $1.35M.
Period endIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 monthIncrease (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month
2012-09-30$8.17K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-12-11
-$30.03K
derived: sum of 2 quarters · filed 2012-12-11
-$105.40K
10-Q/A · filed 2012-12-11
-$29.34K
derived: sum of 4 quarters · filed 2012-12-11
2012-06-30-$38.19K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-30
-$113.56K
10-Q/A · filed 2012-08-30
-$37.51K
derived: sum of 3 quarters · filed 2012-08-30
-$38.94K
derived: sum of 4 quarters · filed 2012-12-11
2012-03-31-$75.37K
10-Q · filed 2012-05-15
$683.00
derived: sum of 2 quarters · filed 2012-05-15
-$744.00
derived: sum of 3 quarters · filed 2012-12-11
-$798.99K
derived: sum of 4 quarters · filed 2012-12-11
2011-12-31$76.05K
derived: 10-K 12 month − 10-Q/A 9 month · filed 2012-03-30
$74.63K
derived: sum of 2 quarters · filed 2012-12-11
-$723.62K
derived: sum of 3 quarters · filed 2012-12-11
-$689.13K
10-K · filed 2012-03-30
2011-09-30-$1.43K
derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2012-12-11
-$799.67K
derived: sum of 2 quarters · filed 2012-12-11
-$765.18K
10-Q/A · filed 2012-12-11
$354.44K
derived: sum of 4 quarters · filed 2012-12-11
2011-06-30-$798.25K
derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-08-30
-$763.75K
10-Q/A · filed 2012-08-30
$355.87K
derived: sum of 3 quarters · filed 2012-08-30
$472.81K
derived: sum of 4 quarters · filed 2012-08-30
2011-03-31$34.49K
10-Q · filed 2012-05-15
$1.15M
derived: sum of 2 quarters · filed 2012-05-15
$1.27M
derived: sum of 3 quarters · filed 2012-05-15
2010-12-31$1.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30
$1.24M
derived: sum of 2 quarters · filed 2012-03-30
$1.35M
10-K · filed 2012-03-30
2010-09-30$116.94K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21
$226.89K
10-Q · filed 2011-11-21
2010-06-30$109.95K
10-Q/A · filed 2011-09-01